Screener
DaVita DVA U.S.Dialysis — Goodwill, Impaired, Accumulated Impairment Loss
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by DaVita in its filing.
Tagged under the XBRL concept us-gaap:GoodwillImpairedAccumulatedImpairmentLoss.
The source filing: DaVita’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 5:03 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000927066-26-000062
| Line item | U.S. dialysis | Other — Ancillary services | Consolidated |
|---|---|---|---|
| Balance at December 31, 2025 | 6,527,616 | 1,017,479 | 7,545,095 |
| Acquisitions | 21,098 | 9,542 | 30,640 |
| Foreign currency and other adjustments | — | 6,578 | 6,578 |
| Balance at March 31, 2026 | $6,548,714 | $1,033,599 | $7,582,313 |
| Balance at March 31, 2026: | |||
| Goodwill | $6,548,714 | $1,187,860 | $7,736,574 |
| Accumulated impairment charges | — | (154,261) | (154,261) |
| $6,548,714 | $1,033,599 | $7,582,313 |
Item 1. Condensed Consolidated Financial Statements:
FAQ
- What is DaVita's u.s.dialysis — goodwill, impaired, accumulated impairment loss?
- DaVita (DVA) reported u.s.dialysis — goodwill, impaired, accumulated impairment loss of $0 in Q1 2026.
- What does u.s.dialysis — goodwill, impaired, accumulated impairment loss mean?
- Tracks the cumulative amount of impairment charges recognized against the goodwill of the U.S. dialysis segment. This metric indicates the extent to which the expected future economic benefits of past acquisitions have declined. It serves as a key indicator of whether historical acquisition prices were justified by subsequent operational performance.
Ask your AI about DaVita's u.s.dialysis — goodwill, impaired, accumulated impairment loss.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude